ASIA PACIFIC BIOCHIPS MARKET 2019-2027

1.    BIOCHIPS MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.3. EVOLUTION & TRANSITION OF BIOCHIPS

2.4. PORTER'S FIVE FORCE ANALYSIS

2.5. MARKET ATTRACTIVENESS MATRIX

2.6. INDUSTRY COMPONENTS

2.7. REGULATORY FRAMEWORK

2.8. VENDOR SCORECARD

2.9. KEY IMPACT ANALYSIS

2.10.            MARKET OPPORTUNITY INSIGHTS

2.11.            INDUSTRY PLAYER POSITIONING

2.12.            KEY MARKET STRATEGIES

2.13.            MARKET DRIVERS

2.13.1.                GROWTH IN PERSONALIZED MEDICINES

2.13.2.                RISING INCIDENCES & TREATMENT OF CANCER

2.13.3.                CONSTANT RISE IN HEALTHCARE SPENDING WORLDWIDE

2.13.4.                INCREASING NUMBER OF INVESTMENTS IN BIOTECHNOLOGY R&D

2.14.            MARKET RESTRAINTS

2.14.1.                INEQUALITY IN HEALTHCARE ACCESS

2.14.2.                INADEQUATE TECHNICAL AWARENESS RELATED TO BIOCHIPS

2.14.3.                COMPLEXITY OF BIOLOGICAL SYSTEMS

2.15.            MARKET OPPORTUNITIES

2.15.1.                DEVELOPMENTS IN BIOCHIP TECHNOLOGY

2.15.2.                ASIA PACIFIC TO OFFER LUCRATIVE GROWTH OPPORTUNITIES

2.15.3.                WIDENING APPLICATION AREAS OF BIOCHIPS

2.16.            MARKET CHALLENGES

2.16.1.                AVAILABILITY OF SUBSTITUTE TECHNOLOGIES

2.16.2.                UNCLEAR REGULATORY GUIDELINES

2.16.3.                COST CONSTRAINTS

3.    BIOCHIPS INDUSTRY OUTLOOK – BY TYPE

3.1. DNA CHIPS

3.1.1.   AGRICULTURAL BIOTECHNOLOGY

3.1.2.   CANCER DIAGNOSTICS & TREATMENT

3.1.3.   DRUG DISCOVERY

3.1.4.   GENE EXPRESSION

3.1.5.   GENOMICS

3.1.6.   SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING

3.1.7.   OTHER DNA CHIPS

3.2. LAB ON A CHIP

3.2.1.   CLINICAL DIAGNOSTICS

3.2.2.   DRUG DISCOVERY

3.2.3.   GENOMICS

3.2.4.   POINT OF CARE & IN VITRO DIAGNOSIS

3.2.5.   PROTEOMICS

3.2.6.   OTHER LAB ON A CHIP

3.3. PROTEIN CHIPS

3.3.1.   DIAGNOSTICS

3.3.2.   DRUG DISCOVERY

3.3.3.   EXPRESSION PROFILING

3.3.4.   HIGH THROUGHPUT SCREENING

3.3.5.   PROTEOMICS

3.3.6.   OTHER PROTEIN CHIPS

3.4. OTHER CHIPS

3.4.1.   CELL ARRAYS

3.4.2.   TISSUE ARRAYS

4.    BIOCHIPS INDUSTRY OUTLOOK - BY SUBSTRATE MATERIAL

4.1. GLASS

4.2. POLYMERS

4.3. SILICON

4.4. OTHER SUBSTRATE MATERIALS

5.    BIOCHIPS INDUSTRY OUTLOOK - BY END USER

5.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES

5.2. HOSPITALS AND DIAGNOSTICS CENTERS

5.3. ACADEMIC AND RESEARCH INSTITUTE

6.    BIOCHIPS INDUSTRY - ASIA PACIFIC

6.1. CHINA

6.2. JAPAN

6.3. INDIA

6.4. SOUTH KOREA

6.5. ASEAN COUNTRIES

6.6. AUSTRALIA AND NEW ZEALAND

6.7. REST OF ASIA PACIFIC

7.    COMPETITIVE LANDSCAPE

7.1. AGILENT TECHNOLOGY INC.

7.2. BIOCHAIN INSTITUTE INC.

7.3. BIOMERIEUX SA

7.4. BIO-RAD LABORATORIES INC.

7.5. CEPHEID INC.

7.6. CYBRDI INC.

7.7. FLUIDIGM CORPORATION

7.8. GAMIDA FOR LIFE GROUP

7.9. ILLUMINA INC.

7.10.            IMGENEX

7.11.            MERCK GMBH

7.12.            ORIGENE TECHNOLOGIES INC.

7.13.            PERKINELMER INC.

7.14.            SAMSUNG ELECTRONICS INC.

7.15.            THERMO FISHER SCIENTIFIC INC.

8.    METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

TABLE 1. MARKET ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET       

TABLE 2. VENDOR SCORECARD OF BIOCHIPS MARKET

TABLE 3. REGULATORY FRAMEWORK OF BIOCHIPS MARKET

TABLE 4. KEY STRATEGIC DEVELOPMENTS IN BIOCHIPS MARKET

TABLE 5. NOTABLE INVESTMENTS MADE IN THE BIOTECHNOLOGY INDUSTRY IN 2017 

TABLE 6. ASIA PACIFIC BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)

TABLE 7. ASIA PACIFIC BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)    

TABLE 8. ASIA PACIFIC BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)      

TABLE 9. ASIA PACIFIC BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)

FIGURE 1. ASIA PACIFIC BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)         

FIGURE 2. PORTER’S FIVE FORCE ANALYSIS OF BIOCHIPS MARKET

FIGURE 3. KEY IMPACT ANALYSIS

FIGURE 4. TIMELINE OF BIOCHIPS

FIGURE 5. MARKET OPPORTUNITY INSIGHTS, BY TYPE, 2018

FIGURE 6. MARKET OPPORTUNITY INSIGHTS, BY END USER, 2018   

FIGURE 7. INDUSTRY COMPONENTS OF BIOCHIPS MARKET   

FIGURE 8. KEY PLAYER POSITIONING IN 2018 (%)

FIGURE 9. COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE        

FIGURE 10. ASIA PACIFIC BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 11. ASIA PACIFIC DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)

FIGURE 12. ASIA PACIFIC DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)

FIGURE 13. ASIA PACIFIC DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)      

FIGURE 14. ASIA PACIFIC DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION)      

FIGURE 15. ASIA PACIFIC DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)           

FIGURE 16. ASIA PACIFIC DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION)       

FIGURE 17. ASIA PACIFIC DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)           

FIGURE 18. ASIA PACIFIC BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)           

FIGURE 19. ASIA PACIFIC LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)

FIGURE 20. ASIA PACIFIC LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)

FIGURE 21. ASIA PACIFIC LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)

FIGURE 22. ASIA PACIFIC LAB ON A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2027 (IN $ MILLION)

FIGURE 23. ASIA PACIFIC LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)      

FIGURE 24. ASIA PACIFIC LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)

FIGURE 25. ASIA PACIFIC BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 26. ASIA PACIFIC PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)

FIGURE 27. ASIA PACIFIC PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)

FIGURE 28. ASIA PACIFIC PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)

FIGURE 29. ASIA PACIFIC PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)

FIGURE 30. ASIA PACIFIC PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)

FIGURE 31. ASIA PACIFIC PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 32. ASIA PACIFIC BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 33. ASIA PACIFIC OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)

FIGURE 34. ASIA PACIFIC OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)

FIGURE 35. ASIA PACIFIC BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS)      

FIGURE 36. ASIA PACIFIC BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)

FIGURE 37. ASIA PACIFIC BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)

FIGURE 38. ASIA PACIFIC BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)

FIGURE 39. ASIA PACIFIC BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS)

FIGURE 40. ASIA PACIFIC BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $ MILLIONS)

FIGURE 41. ASIA PACIFIC BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)

FIGURE 42. ASIA PACIFIC BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)           

FIGURE 43. CHINA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)        

FIGURE 44. JAPAN BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)        

FIGURE 45. INDIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)          

FIGURE 46. SOUTH KOREA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)    

FIGURE 47. ASEAN COUNTRIES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)       

FIGURE 48. AUSTRALIA & NEW ZEALAND BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 

FIGURE 49. REST OF ASIA-PACIFIC BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)